Effects of systemic inhibition of Rho kinase on blood pressure and renal haemodynamics in diabetic rats

R. Komers, T. T. Oyama, D. R. Beard, Sharon Anderson

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Background and Purpose The RhoA/Rho associated kinases (ROCK) pathway has been implicated in the pathophysiology of diabetic nephropathy (DN). Early stages of diabetes are associated with renal haemodynamic changes, contributing to later development of DN. However, the role of RhoA/ROCK, known regulators of vascular tone, in this process has not been studied. Experimental Approach Blood pressure (BP), glomerular filtration (GFR), effective renal plasma flow and filtration fraction (FF) in response to the ROCK inhibitors Y27632 (0.1 and 0.5 mg·kg -1) and fasudil (0.3 and 1.5 mg·kg -1) were examined in streptozotocin-diabetic rats and non-diabetic controls. Key Results Diabetic rats demonstrated baseline increases in GFR and FF. In contrast to similar decreases in BP in diabetic and control rats, renal vasodilator effects and a decrease in FF, following ROCK inhibition were observed only in diabetic rats. The vasodilator effects of Y27632 and a further decrease in FF, were also detected in diabetic rats pretreated with the angiotensin antagonist losartan. The effects of ROCK inhibitors in diabetic rats were modulated by prior protein kinase C (PKC)β inhibition with ruboxistaurin, which abolished their effects on FF. Consistent with the renal vasodilator effects, the ROCK inhibitors reduced phosphorylation of myosin light chain in diabetic kidneys. Conclusions and Implications The results indicate greater dependence of renal haemodynamics on RhoA/ROCK and beneficial haemodynamic effects of ROCK inhibitors in diabetes, which were additive to the effects of losartan. In this process, the RhoA/ROCK pathway operated downstream of or interacted with, PKCβ in some segments of the renal vascular tree.

Original languageEnglish (US)
Pages (from-to)163-174
Number of pages12
JournalBritish Journal of Pharmacology
Volume162
Issue number1
DOIs
StatePublished - Jan 2011

Fingerprint

rho-Associated Kinases
Hemodynamics
Blood Pressure
Kidney
Vasodilator Agents
Losartan
Diabetic Nephropathies
Protein Kinase C
ruboxistaurin
Blood Vessels
Effective Renal Plasma Flow
Myosin Light Chains
Angiotensins
Streptozocin
Phosphorylation

Keywords

  • diabetic nephropathy
  • effective renal plasma flow
  • fasudil
  • myosin light chain
  • Rho associated kinase
  • RhoA GTPase
  • ruboxistaurin
  • Y27632

ASJC Scopus subject areas

  • Pharmacology

Cite this

Effects of systemic inhibition of Rho kinase on blood pressure and renal haemodynamics in diabetic rats. / Komers, R.; Oyama, T. T.; Beard, D. R.; Anderson, Sharon.

In: British Journal of Pharmacology, Vol. 162, No. 1, 01.2011, p. 163-174.

Research output: Contribution to journalArticle

@article{5b9d9246d43f4268a19ce7abf2c9c82b,
title = "Effects of systemic inhibition of Rho kinase on blood pressure and renal haemodynamics in diabetic rats",
abstract = "Background and Purpose The RhoA/Rho associated kinases (ROCK) pathway has been implicated in the pathophysiology of diabetic nephropathy (DN). Early stages of diabetes are associated with renal haemodynamic changes, contributing to later development of DN. However, the role of RhoA/ROCK, known regulators of vascular tone, in this process has not been studied. Experimental Approach Blood pressure (BP), glomerular filtration (GFR), effective renal plasma flow and filtration fraction (FF) in response to the ROCK inhibitors Y27632 (0.1 and 0.5 mg·kg -1) and fasudil (0.3 and 1.5 mg·kg -1) were examined in streptozotocin-diabetic rats and non-diabetic controls. Key Results Diabetic rats demonstrated baseline increases in GFR and FF. In contrast to similar decreases in BP in diabetic and control rats, renal vasodilator effects and a decrease in FF, following ROCK inhibition were observed only in diabetic rats. The vasodilator effects of Y27632 and a further decrease in FF, were also detected in diabetic rats pretreated with the angiotensin antagonist losartan. The effects of ROCK inhibitors in diabetic rats were modulated by prior protein kinase C (PKC)β inhibition with ruboxistaurin, which abolished their effects on FF. Consistent with the renal vasodilator effects, the ROCK inhibitors reduced phosphorylation of myosin light chain in diabetic kidneys. Conclusions and Implications The results indicate greater dependence of renal haemodynamics on RhoA/ROCK and beneficial haemodynamic effects of ROCK inhibitors in diabetes, which were additive to the effects of losartan. In this process, the RhoA/ROCK pathway operated downstream of or interacted with, PKCβ in some segments of the renal vascular tree.",
keywords = "diabetic nephropathy, effective renal plasma flow, fasudil, myosin light chain, Rho associated kinase, RhoA GTPase, ruboxistaurin, Y27632",
author = "R. Komers and Oyama, {T. T.} and Beard, {D. R.} and Sharon Anderson",
year = "2011",
month = "1",
doi = "10.1111/j.1476-5381.2010.01031.x",
language = "English (US)",
volume = "162",
pages = "163--174",
journal = "British Journal of Pharmacology",
issn = "0007-1188",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - Effects of systemic inhibition of Rho kinase on blood pressure and renal haemodynamics in diabetic rats

AU - Komers, R.

AU - Oyama, T. T.

AU - Beard, D. R.

AU - Anderson, Sharon

PY - 2011/1

Y1 - 2011/1

N2 - Background and Purpose The RhoA/Rho associated kinases (ROCK) pathway has been implicated in the pathophysiology of diabetic nephropathy (DN). Early stages of diabetes are associated with renal haemodynamic changes, contributing to later development of DN. However, the role of RhoA/ROCK, known regulators of vascular tone, in this process has not been studied. Experimental Approach Blood pressure (BP), glomerular filtration (GFR), effective renal plasma flow and filtration fraction (FF) in response to the ROCK inhibitors Y27632 (0.1 and 0.5 mg·kg -1) and fasudil (0.3 and 1.5 mg·kg -1) were examined in streptozotocin-diabetic rats and non-diabetic controls. Key Results Diabetic rats demonstrated baseline increases in GFR and FF. In contrast to similar decreases in BP in diabetic and control rats, renal vasodilator effects and a decrease in FF, following ROCK inhibition were observed only in diabetic rats. The vasodilator effects of Y27632 and a further decrease in FF, were also detected in diabetic rats pretreated with the angiotensin antagonist losartan. The effects of ROCK inhibitors in diabetic rats were modulated by prior protein kinase C (PKC)β inhibition with ruboxistaurin, which abolished their effects on FF. Consistent with the renal vasodilator effects, the ROCK inhibitors reduced phosphorylation of myosin light chain in diabetic kidneys. Conclusions and Implications The results indicate greater dependence of renal haemodynamics on RhoA/ROCK and beneficial haemodynamic effects of ROCK inhibitors in diabetes, which were additive to the effects of losartan. In this process, the RhoA/ROCK pathway operated downstream of or interacted with, PKCβ in some segments of the renal vascular tree.

AB - Background and Purpose The RhoA/Rho associated kinases (ROCK) pathway has been implicated in the pathophysiology of diabetic nephropathy (DN). Early stages of diabetes are associated with renal haemodynamic changes, contributing to later development of DN. However, the role of RhoA/ROCK, known regulators of vascular tone, in this process has not been studied. Experimental Approach Blood pressure (BP), glomerular filtration (GFR), effective renal plasma flow and filtration fraction (FF) in response to the ROCK inhibitors Y27632 (0.1 and 0.5 mg·kg -1) and fasudil (0.3 and 1.5 mg·kg -1) were examined in streptozotocin-diabetic rats and non-diabetic controls. Key Results Diabetic rats demonstrated baseline increases in GFR and FF. In contrast to similar decreases in BP in diabetic and control rats, renal vasodilator effects and a decrease in FF, following ROCK inhibition were observed only in diabetic rats. The vasodilator effects of Y27632 and a further decrease in FF, were also detected in diabetic rats pretreated with the angiotensin antagonist losartan. The effects of ROCK inhibitors in diabetic rats were modulated by prior protein kinase C (PKC)β inhibition with ruboxistaurin, which abolished their effects on FF. Consistent with the renal vasodilator effects, the ROCK inhibitors reduced phosphorylation of myosin light chain in diabetic kidneys. Conclusions and Implications The results indicate greater dependence of renal haemodynamics on RhoA/ROCK and beneficial haemodynamic effects of ROCK inhibitors in diabetes, which were additive to the effects of losartan. In this process, the RhoA/ROCK pathway operated downstream of or interacted with, PKCβ in some segments of the renal vascular tree.

KW - diabetic nephropathy

KW - effective renal plasma flow

KW - fasudil

KW - myosin light chain

KW - Rho associated kinase

KW - RhoA GTPase

KW - ruboxistaurin

KW - Y27632

UR - http://www.scopus.com/inward/record.url?scp=78650162527&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78650162527&partnerID=8YFLogxK

U2 - 10.1111/j.1476-5381.2010.01031.x

DO - 10.1111/j.1476-5381.2010.01031.x

M3 - Article

VL - 162

SP - 163

EP - 174

JO - British Journal of Pharmacology

JF - British Journal of Pharmacology

SN - 0007-1188

IS - 1

ER -